What is CJC-1295 No DAC?

CJC-1295 No DAC is a short-acting GHRH analog that tells the pituitary gland to release a single growth hormone pulse.

What is the common starting dose for CJC-1295 No DAC?

A common starting dose is 100 mcg once daily pre-bed in a fasted window.

How do you reconstitute a 10 mg CJC-1295 No DAC vial?

Use a 10 mg vial with 3 mL bacteriostatic water.

How is CJC-1295 No DAC different from CJC-1295 with DAC?

The No DAC version is short-acting and usually dosed daily, while the DAC version lasts 6–8 days.

Why is CJC-1295 No DAC paired with Ipamorelin?

Both compounds push different pathways to create a larger GH pulse.

What are the most common side effects?

Common effects include flushing, headache, injection-site redness, and mild water retention.

Is CJC-1295 No DAC FDA-approved?

No, it is not FDA-approved for any use.

peppersite

Hormone-relatedsubcutaneous

CJC-1295

GHRH analog discussed for GH axis support.

Researched for

Body CompositionMetabolic HealthSleepRecoveryPerformance Recovery

Watch first

1:03

0:001:03

You will almost never hear ipamorelin mentioned without CJC-1295, and there is a real reason researchers pair them.

What our audits found

Expert commentarystrongest evidence cited across 2 audits · expert commentary

Your COA Says 99.9%. That Number Can Be True and the Vial Still Be Short.

Purity tells you the composition of what's in the vial. It says nothing about how much is in there, and almost every certificate published to buyers answers the first question and quietly skips the second.

3 CLAIMS GRADED

What sources report

Reference, not a recommendation

These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for CJC-1295 or for anything else, and nothing below has been checked against the study it came from.

Amount	Frequency	Route	Reported by
100 mcg per injection (1-2 mcg/kg saturation dose)	2-3 times daily8-12 weeks	subcutaneous	Peptide Protocol Wiki What it saysHide (secondary reference; provider confirmation required).
Standard: 200 mcg, once daily · Low: 100 mcg, once daily · High: 300 mcg, up to 3x daily	1-3 times daily8-12 weeks · 4-6 weeks off	Subcutaneous (SubQ)	Peptide Dosing Protocols What it saysHide (secondary reference; provider confirmation required). Half-life: About 30 minutes. The standard dose is 200 mcg, administered once daily.
Non-DAC version referenced at 100-300 mcg (0.1-0.3 mg) per dose due to short half-life. Empty stomach preferred; avoid co-administration with carbohydrates or fats (insulin interference with GH release).	1-3x daily · Morning, pre-workout, or before bedOn-cycle 8-12 weeks, off-cycle 6-12 weeks	subcutaneous	Peptide Therapy Reference Text, internal KB v4 What it saysHide (Aug 2026), secondary reference; provider confirmation required.

100 mcg per injection (1-2 mcg/kg saturation dose)

Frequency: 2-3 times daily8-12 weeks
Route: subcutaneous
Reported by: Peptide Protocol Wiki
What it saysHide
(secondary reference; provider confirmation required).

Standard: 200 mcg, once daily · Low: 100 mcg, once daily · High: 300 mcg, up to 3x daily

Frequency: 1-3 times daily8-12 weeks · 4-6 weeks off
Route: Subcutaneous (SubQ)
Reported by: Peptide Dosing Protocols
What it saysHide
(secondary reference; provider confirmation required). Half-life: About 30 minutes. The standard dose is 200 mcg, administered once daily.

Non-DAC version referenced at 100-300 mcg (0.1-0.3 mg) per dose due to short half-life. Empty stomach preferred; avoid co-administration with carbohydrates or fats (insulin interference with GH release).

Reconstitution, as reported

Bacteriostatic water
10 mg vial with 3 mL bacteriostatic water

CJC-1295

Your COA Says 99.9%. That Number Can Be True and the Vial Still Be Short.

Tesamorelin Is Approved. CJC-1295 Is Living Off Its Reputation.

How it is thought to work

Reported side effects

Who should avoid it

What gets monitored

What sources report

Common questions